Medicine & Life Sciences
Aminolevulinic Acid
19%
Anti-Bacterial Agents
17%
Carcinoma
28%
Castration
16%
Ceftazidime
17%
Clinical Studies
62%
Cystectomy
16%
Cystitis
36%
DQ 2556
16%
Escherichia coli
23%
Flucytosine
20%
Gatifloxacin
21%
Glioblastoma
20%
Glioma
26%
Homeobox Genes
17%
Inverted Papilloma
15%
Kidney
25%
Lewis Lung Carcinoma
31%
Limb Buds
41%
Lung Neoplasms
15%
Mechanistic Target of Rapamycin Complex 1
39%
Moxalactam
16%
Neoplasms
33%
Optogenetics
19%
Osteoblasts
36%
Osteogenesis
19%
pembrolizumab
20%
Pharmacokinetics
16%
Platelet-Derived Growth Factor Receptors
23%
Pluripotent Stem Cells
43%
Prostate
20%
Prostate-Specific Antigen
17%
Prostatectomy
24%
Prostatic Neoplasms
23%
Prostatitis
28%
quinoline
22%
Recurrence
16%
Semaphorin-3A
33%
sparfloxacin
22%
Survival
16%
Therapeutics
20%
TOR Serine-Threonine Kinases
35%
Transitional Cell Carcinoma
24%
Urethritis
19%
Urinary Bladder
22%
Urinary Bladder Neoplasms
63%
Urinary Tract
19%
Urinary Tract Infections
96%
Urine
24%
Urology
34%
Chemical Compounds
2,3,5-triphenyltetrazolium Chloride
13%
Antibacterial
55%
Antimicrobial Agent
23%
Autophagy Inhibitor
14%
Cefclidin
16%
Cefdinir
13%
Cefepime
12%
Cefodizime
14%
Cefoperazone
12%
Cefpirome
13%
Ceftazidime
26%
Cell Marker
15%
Cell Surface Marker
12%
Cephem
21%
Ciprofloxacin
14%
D-Serine
11%
Developmental
8%
Dose
25%
Drug
27%
Energy Balance
10%
Fleroxacin
12%
Flucytosine
27%
Glucose
10%
Glutamine
8%
Intracranial
11%
Light Blue
8%
Marker
12%
Meropenem
11%
Minimum Inhibitory Concentration
8%
Nasal
9%
Norfloxacin
19%
Ofloxacin
16%
Oligomycin
8%
Once Daily
12%
Oncogenic
27%
Osteogenic
9%
Parenteral
9%
Pharmacokinetics
15%
Piperacillin
12%
Plate Like Crystal
17%
Proliferative
20%
Safranin O
11%
Small Interfering RNA
15%
Sparfloxacin
23%
Sphere
10%
Strain
34%
Tamoxifen
10%
Tazobactam
12%
Twice Daily
28%
Urological
100%